CIK 0001034842
- Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943248524
- Phone
- +1 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-01 | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2021-04-01 | Schorno Dean L EVP &Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-04-01 | RODRIGUEZ RAUL R CEO, President | Grant or award · Stock Option (Right to Buy) | +162,500 | 162,500 | ||
| 2021-01-27 | Dummer Wolfgang EVP & CMO | Grant or award · Stock Option(right to buy) | +125,000 | 125,000 | ||
| 2021-01-27 | Dummer Wolfgang EVP & CMO | Grant or award · Stock Option (right to buy) | +37,500 | 37,500 | ||
| 2021-01-27 | Santos David A EVP, Chief Commercial Officer | Grant or award · Stock Option(right to buy) | +137,500 | 137,500 | ||
| 2021-01-27 | Schorno Dean L EVP &Chief Financial Officer | Grant or award · Stock Option(right to buy) | +112,500 | 112,500 | ||
| 2021-01-27 | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. | Grant or award · Stock Option(right to buy) | +125,000 | 125,000 | ||
| 2021-01-27 | RODRIGUEZ RAUL R CEO, President | Grant or award · Stock Option(right to buy) | +525,000 | 525,000 | ||
| 2020-08-19 | Santos David A EVP, Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2020-05-15 | Wasman Jane Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2020-05-15 | Katkin Keith Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2020-05-15 | Kotzin Brian L. Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2020-05-15 | LAPOINTE ANTHONY GREGG Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2020-05-15 | Goodwin Bradford S Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2020-05-15 | MOOS WALTER H Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2020-05-15 | LYONS GARY A Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2020-05-14 | Cabatuan Nelson VP,Finance & Princ.Acctg. Off. | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-02-06 | Cabatuan Nelson VP,Finance & Princ.Acctg. Off. | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2020-02-06 | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 |
Page 13 of 16 · 310 trades